Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir

被引：3
|
作者：
Wang, Mo [1 ,2 ]
Zhang, Lu [2 ]
Huo, Xiaohong [1 ]
Zhang, Zhenfeng [2 ]
Zhang, Wanbin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Frontiers Sci Ctr Transformat Mol, Shanghai Key Lab Mol Engn Chiral Drugs, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China
来源：
CURRENT PROTOCOLS | 2021年 / 1卷 / 12期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
anti-COVID-19; drug; asymmetric phosphorylation; chiral bicyclic imidazole; organocatalysis; ENANTIOSELECTIVE C-ACYLATION; KINETIC RESOLUTION; GS-5734; DESIGN; EBOLA;
D O I：
10.1002/cpz1.303
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Remdesivir has become an important compound for the treatment of COVID-19. Here, we describe the catalytic asymmetric synthesis of this anti-COVID-19 drug. First, the P-racemic phosphoryl chloride is synthesized in a facile procedure. Then, it is possible to obtain the protected remdesivir via the organocatalytic asymmetric phosphorylation of protected nucleoside GS441524 with P-racemic phosphoryl chloride catalyzed by chiral bicyclic imidazole. Finally, remdesivir is easily prepared by deprotection. (c) 2021 Wiley Periodicals LLC.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Research and development of Chinese anti-COVID-19 drugs
    Xiwei Ji
    Xiangrui Meng
    Xiao Zhu
    Qingfeng He
    Yimin Cui
    ActaPharmaceuticaSinicaB, 2022, 12 (12) : 4271 - 4286
  • [32] Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
    Liu, Dongling
    Zeng, Xiang
    Ding, Zufeng
    Lv, Fenghua
    Mehta, Jawahar L.
    Wang, Xianwei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [33] Progress in the Research and Development of Anti-COVID-19 Drugs
    Huang, Lianzhou
    Chen, Yuanqiu
    Xiao, Ji
    Luo, Weisheng
    Li, Feng
    Wang, Yuan
    Wang, Yiliang
    Wang, Yifei
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [34] Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize
    Mbikay, Majambu
    Chretien, Michel
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] CNS penetration of potential anti-COVID-19 drugs
    Peter J. Richardson
    Silvia Ottaviani
    Alessandro Prelle
    Justin Stebbing
    Giacomo Casalini
    Mario Corbellino
    Journal of Neurology, 2020, 267 : 1880 - 1882
  • [36] DARPins stack up as anti-COVID-19 agents
    Nature Biotechnology, 2020, 38 : 1369 - 1369
  • [37] Anti-COVID-19 measurements for hidradenitis suppurativa patients
    Chandran, Nisha Suyien
    Lee, Ji Hae
    Kurokawa, Ichiro
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 23 - 26
  • [38] Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrins
    Kumar, Vipul
    Meidinna, Hazna Noor
    Kaul, Sunil C.
    Gupta, Dharmender
    Ishida, Yoshiyuki
    Terao, Keiji
    Vrati, Sudhanshu
    Sundar, Durai
    Wadhwa, Renu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (06): : 2890 - 2900
  • [39] CNS penetration of potential anti-COVID-19 drugs
    Richardson, Peter J.
    Ottaviani, Silvia
    Prelle, Alessandro
    Stebbing, Justin
    Casalini, Giacomo
    Corbellino, Mario
    JOURNAL OF NEUROLOGY, 2020, 267 (07) : 1880 - 1882
  • [40] Acute myocarditis associated with anti-COVID-19 vaccination
    Nevet, Alon
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2021, 10 (02) : 196 - 197
12345